MCM
KIDS icon

Manchester Capital Management’s OrthoPediatrics KIDS Stock Holding History

Manchester Capital Management’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17
Closed -$1K – 1086
2021
Q2 		$1K Buy
+17
New +$977 ﹤0.01% 755

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Manchester Capital Management's KIDS Position: Q3 2021 in Review

Manchester Capital Management sold out of OrthoPediatrics (KIDS) in Q3 2021, closing a stake of 17 shares — an estimated $1K sold.

Manchester Capital Management first reported a position in KIDS in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 143 funds tracked by Wall St. Rank hold KIDS as of Q3 2021.

  • Manchester Capital Management reported no remaining OrthoPediatrics position as of Q3 2021 after selling out during the quarter.
  • Manchester Capital Management sold 17 OrthoPediatrics shares in Q3 2021, an estimated $1K.
  • Manchester Capital Management first reported a position in OrthoPediatrics in Q2 2021 and held it in 1 quarter.
  • Manchester Capital Management's OrthoPediatrics position peaked at $1K in Q2 2021.
  • 143 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2021.

Based on Manchester Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.